Clin Res Cardiol (2023). https://doi.org/10.1007/s00392-023-02180-w |
||||||||||||||||||||||||||||||||||||||||||||||||||
Outcomes of Endovascular Treatment for Popliteal Artery Disease | ||||||||||||||||||||||||||||||||||||||||||||||||||
A. M. Müller1, L. Löhn-Kannengießer1, C. Bradaric1, R. Dirschinger1, T. Koppara1, K. Bergmann1, A. Kafka1, V. Kehl2, M. Fusaro3, S. Cassese4, E. Xhepa5, I. Ott6, A. Kastrati5, K.-L. Laugwitz1, T. Ibrahim1, für die Studiengruppe: ISAResearch Center | ||||||||||||||||||||||||||||||||||||||||||||||||||
1Klinik und Poliklinik für Innere Medizin I, Klinikum rechts der Isar der Technischen Universität München, München; 2Institut für KI und Informatik in der Medizin/ Klinikum rechts der Isar, München; 3Interventionelle Kardiologie, Klinik Vincentinum, Augsburg; 4Deutsches Herzzentrum München, München; 5Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, München; 6Medizinische Klinik I, Kardiologie, Helios Klinikum Pforzheim, Pforzheim; | ||||||||||||||||||||||||||||||||||||||||||||||||||
All endovascular procedures of popliteal artery lesions (n=227) performed in 197 patients between December 2009 and January 2018 at our institution were retrospectively analyzed. The overall technical success rate was 98% and yielded 99% for stenoses (n=145) and 97% for occlusions (n=82). In a median follow-up of 10 months, the overall rate of restenosis was 23%. After 1 and 2 years, the primary patency rates were 76% and 55% and the secondary patency rate was 100%, respectively. The estimated probability of restenosis was significantly higher in stented lesions (stent vs. no stent; 36.0% vs. 19.1%; p=0.030). Multivariate analysis identified stent implantation (hazard ratio: 2.4; overall P=0.010) and diabetes (hazard ratio 2.0; P=0.023) as significant predictors for the development of restenosis. In conclusion, endovascular therapy for popliteal artery disease was associated with high technical success rates and accompanied with a promising long-term outcome, particularly in lesions treated with balloon angioplasty alone.
Abbreviations: CAD, coronary artery disease; MI, myocardial infarction; PTA, percutaneous transluminal angioplasty, PAD, peripheral artery disease.
Table 2. Lesion Characteristics (n/N (%) unless otherwise stated).
Table 3. Procedural Characteristics (n/N (%) unless otherwise stated).
Abbreviations: PTA, Percutaneous Transluminal Angioplasty; POBA, Plain Old Balloon Angioplasty; DEB, drug-eluting balloon; BMS, bare-metal stent; DES, drug-eluting stent.
|
||||||||||||||||||||||||||||||||||||||||||||||||||
https://dgk.org/kongress_programme/jt2023/aP2111.html |